Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation

Allopurinol is a xanthine oxidase inhibitor that lowers serum uric acid and is used to prevent acute gout flares in patients with gout. Observational and small interventional studies have suggested beneficial cardiovascular effects of allopurinol. To determine whether allopurinol improves major card...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Health technology assessment (Winchester, England) Ročník 28; číslo 18; s. 1 - 55
Hlavní autoři:	Mackenzie, Isla S, Hawkey, Christopher J, Ford, Ian, Greenlaw, Nicola, Pigazzani, Filippo, Rogers, Amy, Struthers, Allan D, Begg, Alan G, Wei, Li, Avery, Anthony J, Taggar, Jaspal S, Walker, Andrew, Duce, Suzanne L, Barr, Rebecca J, Dumbleton, Jennifer S, Rooke, Evelien D, Townend, Jonathan N, Ritchie, Lewis D, MacDonald, Thomas M
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England NIHR Journals Library 01.03.2024
Témata:	allopurinol cardiovascular system cause of death cost-benefit analysis gout humans multicentre studies myocardial infarction myocardial ischaemia prospective studies randomised controlled trials stroke united kingdom xanthine oxidase MULTICENTRE STUDIES GOUT HUMANS CARDIOVASCULAR SYSTEM ALLOPURINOL STROKE MYOCARDIAL ISCHAEMIA PROSPECTIVE STUDIES CAUSE OF DEATH RANDOMISED CONTROLLED TRIALS XANTHINE OXIDASE MYOCARDIAL INFARCTION UNITED KINGDOM COST-BENEFIT ANALYSIS
ISSN:	2046-4924, 1366-5278, 2046-4924
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!